Georgios Tsermoulas

Mindelsohn Way
Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Cerebrospinal fluid shunting or dural venous sinus stenting to preserve vision in idiopathic intracranial hypertension (IIH Intervention): protocol for an open-label, multicentre, randomised controlled phase IIb trial.

Cerebrospinal fluid shunting or dural venous sinus stenting to preserve vision in idiopathic intracranial hypertension (IIH Intervention): protocol for an open-label, multicentre, randomised controlled phase IIb trial.

Journal: BMJ open

Published: August 03, 2026

Ten-year spontaneous intracranial hypotension with acquired tonsillar descent and syringomyelia from a T3-4 ventral dural defect: importance of digital subtraction myelography localization and role of direct repair. Illustrative case.

Ten-year spontaneous intracranial hypotension with acquired tonsillar descent and syringomyelia from a T3-4 ventral dural defect: importance of digital subtraction myelography localization and role of direct repair. Illustrative case.

Journal: Journal of neurosurgery. Case lessons

Published: April 12, 2026

Case Report: Vision-threatening manifestations of choroidal osteomas and papilloedema in presumed Camurati-Engelmann disease.

Case Report: Vision-threatening manifestations of choroidal osteomas and papilloedema in presumed Camurati-Engelmann disease.

Journal: Frontiers in neurology

Published: March 16, 2026

Reconceptualizing intracranial pressure: the role of amplitude in comprehensive reporting.

Reconceptualizing intracranial pressure: the role of amplitude in comprehensive reporting.

Journal: Journal of neurosurgery

Published: January 22, 2026

Management of endocrine disease: update on the management of pituitary apoplexy.

Management of endocrine disease: update on the management of pituitary apoplexy.

Journal: European journal of endocrinology

Published: January 07, 2026

Comment on "Surgical versus endovascular treatment for idiopathic intracranial hypertension".

Comment on "Surgical versus endovascular treatment for idiopathic intracranial hypertension".

Journal: Neuro-Chirurgie

Published: November 06, 2025

Stenting versus shunting in sight-threatening idiopathic intracranial hypertension: genuine equipoise.

Stenting versus shunting in sight-threatening idiopathic intracranial hypertension: genuine equipoise.

Journal: Practical neurology

Published: November 05, 2025

Calcitonin gene-related peptide induces headache attacks in people with idiopathic intracranial hypertension.

Calcitonin gene-related peptide induces headache attacks in people with idiopathic intracranial hypertension.

Journal: Brain : a journal of neurology

Published: October 25, 2025

Ectopic craniopharyngiomas.

Ectopic craniopharyngiomas.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: October 08, 2025

Treating Sight Threatening Papilloedema in Idiopathic Intracranial Hypertension: Temporary Versus Permanent Intervention.

Treating Sight Threatening Papilloedema in Idiopathic Intracranial Hypertension: Temporary Versus Permanent Intervention.

Journal: European journal of neurology

Published: July 03, 2025

Infographic: Landmark trials in Neuro-Ophthalmology-results of the phase II Idiopathic Intracranial Hypertension Pressure Trial.

Infographic: Landmark trials in Neuro-Ophthalmology-results of the phase II Idiopathic Intracranial Hypertension Pressure Trial.

Journal: Eye (London, England)

Published: June 14, 2025

P2X7R-mediated IL-1β release by human brain tissue: the impact of CNS-penetrant potential therapeutics.

P2X7R-mediated IL-1β release by human brain tissue: the impact of CNS-penetrant potential therapeutics.

Journal: Brain : a journal of neurology

Published: April 22, 2025

Showing 1-12 of 59

Last Updated: 09/26/2026